210 related articles for article (PubMed ID: 7694581)
21. Cloning and expression of the complete SIVagm pol region in E. coli. Purification and partial characterization of the reverse transcriptase.
Baier M; Behr E; Kurth R; König H
Arzneimittelforschung; 1990 Nov; 40(11):1284-7. PubMed ID: 1707622
[TBL] [Abstract][Full Text] [Related]
22. Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis.
Pandey VN; Kaushik N; Rege N; Sarafianos SG; Yadav PN; Modak MJ
Biochemistry; 1996 Feb; 35(7):2168-79. PubMed ID: 8652558
[TBL] [Abstract][Full Text] [Related]
23. Purification and kinetic characterization of equine infectious anemia virus reverse transcriptase.
Thomas DA; Furman PA
Biochem Biophys Res Commun; 1991 Nov; 180(3):1365-71. PubMed ID: 1719980
[TBL] [Abstract][Full Text] [Related]
24. Structure of equine infectious anemia virus proteinase complexed with an inhibitor.
Gustchina A; Kervinen J; Powell DJ; Zdanov A; Kay J; Wlodawer A
Protein Sci; 1996 Aug; 5(8):1453-65. PubMed ID: 8844837
[TBL] [Abstract][Full Text] [Related]
25. Chimeric thermostable DNA polymerases with reverse transcriptase and attenuated 3'-5' exonuclease activity.
Schönbrunner NJ; Fiss EH; Budker O; Stoffel S; Sigua CL; Gelfand DH; Myers TW
Biochemistry; 2006 Oct; 45(42):12786-95. PubMed ID: 17042497
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.
Chen H; McBroom DG; Zhu YQ; Gold L; North TW
Biochemistry; 1996 May; 35(21):6923-30. PubMed ID: 8639644
[TBL] [Abstract][Full Text] [Related]
27. The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2.
Shaharabany M; Hizi A
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):883-8. PubMed ID: 1722105
[TBL] [Abstract][Full Text] [Related]
28. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
[TBL] [Abstract][Full Text] [Related]
29. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
30. Initiation of (-) strand DNA synthesis from tRNA(3Lys) on lentiviral RNAs: implications of specific HIV-1 RNA-tRNA(3Lys) interactions inhibiting primer utilization by retroviral reverse transcriptases.
Arts EJ; Stetor SR; Li X; Rausch JW; Howard KJ; Ehresmann B; North TW; Wöhrl BM; Goody RS; Wainberg MA; Grice SF
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10063-8. PubMed ID: 8816751
[TBL] [Abstract][Full Text] [Related]
31. A leucine zipper-like motif may mediate HIV reverse transcriptase subunit binding.
Baillon JG; Nashed NT; Kumar A; Wilson SH; Jerina DM
New Biol; 1991 Oct; 3(10):1015-9. PubMed ID: 1722701
[No Abstract] [Full Text] [Related]
32. dUTPase from the retrovirus equine infectious anemia virus: high-level expression in Escherichia coli and purification.
Bergman AC; Björnberg O; Nord J; Rosengren AM; Nyman PO
Protein Expr Purif; 1995 Jun; 6(3):379-87. PubMed ID: 7663176
[TBL] [Abstract][Full Text] [Related]
33. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
[TBL] [Abstract][Full Text] [Related]
35. Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.
Powell DJ; Bur D; Wlodawer A; Gustchina A; Payne SL; Dunn BM; Kay J
Eur J Biochem; 1996 Oct; 241(2):664-74. PubMed ID: 8917470
[TBL] [Abstract][Full Text] [Related]
36. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.
Borroto-Esoda K; Boone LR
J Virol; 1991 Apr; 65(4):1952-9. PubMed ID: 1705993
[TBL] [Abstract][Full Text] [Related]
37. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
Wilhelm M; Boutabout M; Wilhelm FX
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
Auwerx J; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
[TBL] [Abstract][Full Text] [Related]
39. [Construction of an infectious clone of equine infectious anemia virus by N-glycosylation reverse-mutations].
Han X; Quan Y; Gao X; Xiang W; Zhou J
Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):287-92. PubMed ID: 18479052
[TBL] [Abstract][Full Text] [Related]
40. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC
J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
